Tijen Onkol

Tijen Onkol

Auto-generated profile, based on publicly available information

Tijen Onkol

Department of Pharmaceutical Chemistry, Faculty of Pharmacy Gazi University 06330 Ankara Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2022 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MQMohammed Qaoud
Mohammed Qaoud
IAIhab Almasri
Ihab Almasri
TÖTijen Önkol
Tijen Önkol
Thiazolidinedione (TZD), a class of drugs that are mainly used to control type 2 diabetes mellitus (T2DM), acts fundamentally as a ligand of peroxisome proliferator-activated receptors (PPARs). Besides activating pathways responsible for glycemic control by enhancing insulin sensitivity and lipid homeostasis, activating PPARs leads to exciting other pathways related to bone formation, inflammation, and cell proliferation. Unfortunately, this diverse effect of activating several pathways may show in some studies adverse health outcomes as osteological, hepatic, cardiovascular, and carcinogenic effects. Thus, a silver demand is present to find and develop new active and potent antiglycemic drugs for treating T2DM. To achieve this goal, the structure of TZD for research is considered a leading structure domain. This review will guide future research in the design of novel TZD derivatives by highlighting the general modifications conducted on the structure component of TZD scaffold affecting their potency, binding efficacy, and selectivity for the control of T2DM.

8 December 2022 in ChemistrySelect
Verified
Journal Article
Closed access
MAMehmet Abdullah Alagöz
Mehmet Abdullah Alagöz
DADidem Akkaya
Didem Akkaya
GAGülnur Arslan
Gülnur Arslan
BUBerk Uludağ
Berk Uludağ
Zeynep ÖZDEMİRZeynep ÖZDEMİR
Zeynep ÖZDEMİR
Suat SariSuat Sari
Suat Sari

1 January 2020 in Brazilian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
OGOzge Gorgu
Ozge Gorgu
EYEngin Yıldırım
Engin Yıldırım
YOYesim Ozkan
Yesim Ozkan
BCBilge Cakır
Bilge Cakır
KEKevser Erol
Kevser Erol
TOTijen Onkol
Tijen Onkol

26 December 2019 in Bioorganic and Medicinal Chemistry Reports
Verified
Journal Article
Closed access
YDYasemin Dundar
Yasemin Dundar
FKFatma Kaynak-Onurdag
Fatma Kaynak-Onurdag
TOTijen Onkol
Tijen Onkol
Bacterial and fungal resistance to almost all antimicrobial agents have been observed in disease causing bacteria and fungi. A series of 3-({4-[substitutedbenzylideneamino]-1-(morpholin-4-ylmethyl)-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl}methyl)-2(3H)-benzothiazolone (6a-6g) were prepared by the reaction of morpholine in the presence of formaldehyde using microwave irradiation with the yield ranging from 50% to 98%. The newly synthesized compounds were characterized on the basis of elemental analysis, IR and 1H-NMR. All the synthesized compounds were tested for their antibacterial activities against Gram + and Gram – bacteria, their clinical isolates and antifungal activities against Candida species in vitro. Many of these compounds exhibited potent antifungal activity, while compound 6g (MIC:32 µg/mL) had comparable activity with ampicillin and gentamycin (MIC: 4 µg/mL) against E.faecalis isolate.